Michael L. Meyers
2015
In 2015, Michael L. Meyers earned a total compensation of $1.4M as Chief Medical Officer at Syndax Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $43,750 |
|---|---|
| Option Awards | $1,205,972 |
| Salary | $140,625 |
| Other | $4,463 |
| Total | $1,394,810 |
Meyers received $1.2M in option awards, accounting for 86% of the total pay in 2015.
Meyers also received $43.8K in non-equity incentive plan, $140.6K in salary and $4.5K in other compensation.
Rankings
In 2015, Michael L. Meyers' compensation ranked 6,346th out of 13,638 executives tracked by ExecPay. In other words, Meyers earned more than 53.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,346 out of 13,638 | 54th |
Division Manufacturing | 2,379 out of 5,187 | 54th |
Major group Chemicals And Allied Products | 859 out of 1,857 | 54th |
Industry group Drugs | 687 out of 1,531 | 55th |
Industry Pharmaceutical Preparations | 534 out of 1,179 | 55th |
Source: SEC filing on April 7, 2017.
Meyers' colleagues
We found two more compensation records of executives who worked with Michael L. Meyers at Syndax Pharmaceuticals in 2015.